Financial Performance Highlights

Q2 FY27 Performance (Quarter Ended September 30, 2026)

  • Revenue from Operations: ₹17.72 crore, representing 35.94% year-on-year growth
  • Profit Before Tax: ₹55.87 lakh (compared to ₹7.30 lakh in Q2 FY26)
  • Net Profit: ₹43.95 lakh (compared to ₹11.58 lakh in Q2 FY26)

H1 FY27 Performance (Half Year Ended September 30, 2026)

  • Revenue from Operations: ₹34.78 crore, representing 30.96% year-on-year growth
  • Profit Before Tax: ₹156.89 lakh, representing 95.43% year-on-year growth (compared to ₹80.28 lakh in H1 FY26)
  • Net Profit: ₹1.05 crore, representing 59.44% year-on-year growth

Corporate Profile

Lotus Eye Hospital and Institute Limited is a hi-tech super-specialty eye-care hospital headquartered in Coimbatore, Tamil Nadu, with presence across Tamil Nadu and Kerala. Registered Office: 770/12, Avinashi Road, Aerodrome Post, Coimbatore – 641 014.

Business Overview

  • Single operating segment under Ind AS 108: "Eye Care related sales and services"
  • Key clinical specialties: Cataract and LASIK, Squint and diabetic retinopathy, Pediatric ophthalmology and cornea, Retina, glaucoma and Oculoplasty, Optical services
  • Technology capabilities: Advanced ophthalmic diagnostic and surgical equipment, technology-enabled eye care solutions

Balance Sheet Highlights

  • Total Assets: Not quantified in disclosure
  • Total Equity: Not quantified in disclosure
  • Borrowings: Comprise current and non-current borrowings (lease liabilities excluded)

Shareholding Pattern (as at September 30, 2026)

  • Promoters & Promoter Group: 40.14%
  • Public Shareholding: 59.86%
  • Equity Share Capital: 2,07,96,330 shares with face value of ₹10

Management Commentary

Chairperson Kavetha Sundaramoorthy stated: "The ambition and objectives is to actualize and institute an earnest, unrelenting and persisting organization."

Managing Director Sangeetha Sundaramoorthy stated: "In this aeon for LOTUS, the importance, emphasis and priority, will always be in ensuring and securing the credence and credibility of our shareholders."

Growth Priorities & Strategic Initiatives

  • Expansion Plans: Expand hospital network across existing and new geographies, strengthen presence in key markets, evaluate new hospitals and satellite centres
  • Operational Priorities: Standardize operating procedures, enhance patient experience and digital integration, improve performance monitoring
  • Clinical Capability: Upgrade ophthalmic diagnostic and surgical infrastructure, adopt advanced technologies in cataract and refractive surgery
  • Growth Outlook: Pursue sustainable growth, strengthen existing centres, balance growth and profitability

Key Opportunities

Growing demand for specialized ophthalmic care, increasing awareness and adoption of advanced treatments, opportunities for geographic expansion, demand for refractive and premium cataract procedures.

Disclaimer

Company noted this presentation is for informational purposes only and does not constitute an offer or recommendation to purchase securities. Contains forward-looking statements subject to risks and uncertainties.